Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VNQ vs GSK✓SelectedUSD · GSKVNQ vs GSK performance historyLatest closeAs of+0.31%11/18
Stock and ETF performance explorer

VNQ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+79.6%
GSK return
+101.2%
Excess return
-21.6%
Maximum drawdown
-42.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-1.3%+1.6%+0.8%
7D-1.9%-3.1%+1.2%-0.7%
30D+4.9%-0.9%+5.8%+5.2%
3M-1.7%-4.2%+2.5%-0.3%
6M+1.9%-1.6%+3.5%+2.0%
YTD+10.6%+2.6%+8.0%+8.2%
1Y+10.7%+6.2%+4.5%+6.8%
3Y+35.3%+55.0%-19.6%+8.0%
5Y+5.1%+42.8%-37.8%-15.0%
10Y+79.6%+102.1%-22.5%+24.2%
All+79.6%+101.2%-21.6%+24.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling